• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN MINI ICD VR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN MINI ICD VR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) Back to Search Results
Model Number D021
Medical Device Problem Codes Failure to Capture (1081); High impedance (1291)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/27/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that this system exhibited pacing impedance measurements greater than 3000 ohms and intermittent loss of capture on the right ventricular (rv) channel.The patient was brought into the clinic and testing confirmed normal impedance measurements and stable threshold measurements.The rv pacing output was increased.It was noted that the lead in question is manufactured by a competitor.No adverse patient effects were reported.
 
Additional Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Additional Manufacturer Narrative
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.Investigation of the available information determined this device exhibited oversensing of noise generated by the minute ventilation (mv)/respiratory sensor that is related to a high impedance condition.Please see the description for more information regarding the specific circumstances of this event.As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event or Problem Description
It was reported that this system exhibited pacing impedance measurements greater than 3000 ohms and intermittent loss of capture on the right ventricular (rv) channel.The patient was brought into the clinic and testing confirmed normal impedance measurements and stable threshold measurements.The rv pacing output was increased.It was noted that the lead in question is manufactured by a competitor.No adverse patient effects were reported.
 
Additional Manufacturer Narrative
The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Pin gage testing, designed to verify proper port dimensions, was completed.Each port measured as expected.The device was then exposed to simulated heart load conditions, and the pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.The associated investigation also determined that this device exhibited intermittent impedance measurements with no conclusive evidence of a malfunction or inadequate lead-to-device connection.
 
Event or Problem Description
It was reported that this system exhibited pacing impedance measurements greater than 3000 ohms and intermittent loss of capture on the right ventricular (rv) channel.The patient was brought into the clinic and testing confirmed normal impedance measurements and stable threshold measurements.The rv pacing output was increased.It was noted that the lead in question is manufactured by a competitor.No adverse patient effects were reported.It was reported that this device was subsequently explanted for normal battery depletion.The device was returned for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN MINI ICD VR
Common Device Name
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key14529847
Report Number2124215-2022-16348
Device Sequence Number12161111
Product Code LWS
UDI-Device Identifier00802526533884
UDI-Public00802526533884
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
P960040/S306
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date04/10/2021
Device Model NumberD021
Device Catalogue NumberD021
Device Lot Number110229
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/28/2022
Supplement Date Received by Manufacturer05/26/2022
05/05/2023
Initial Report FDA Received Date05/27/2022
Supplement Report FDA Received Date06/10/2022
06/01/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/06/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient Age2 YR
Patient SexMale
-
-